Colossal
colossal.comOperator of a bioscience and genetic engineering company committed to building radical new technologies to advance the field of genomics.
LBX PPS
1Y return
$9.97
Implied Valuation
$4.1B
-59.9% premium
Last Round
Sep 2025
$24.89
Series C · $10.2B
Activity
2.8
#92 most active
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...
Signals
1 latest
Colossal Biosciences in Talks to Raise New Capital at $20B–$30B Valuation
Colossal Biosciences is reportedly in talks to raise new capital at a valuation of $20B–$30B, according to reports from TechCrunch and Axios. The de-extinction startup, known for its woolly mammoth project, would see a significant valuation jump if the round closes.
Source: TechCrunch